Comprehensive Study Notes on CNS Pharmacology and Endocrine Basics

Neurological Foundations and Neurotransmitters

• Situations occur where the blood brain barrier can be bypassed.
• Glutamine: This is identified as the excitatory neurotransmitter.
• GABA: This is identified as the inhibitory neurotransmitter.
• Catecholamides: There are three main catecholamides discussed:
  • Dopamine.
  • Epinephrine ($Epi$).
  • Norepinephrine ($Norepi$).
• Release of Catecholamides:
  • Epinephrine and thorabenoprine are mainly released.
  • Adrenal Cortex Layers ($GFR$):
  • Glomerulosa.
  • Fasciculata.
  • Reticularis: Releases androgens and sex hormones.
  • The functional mnemonic shared is "GFR MGA. S s s. So sugar sex."
• CNS drug relevance: Used for psychotic diseases and movement issues related to extrapyramidal problems.

Introduction to Sedative-Hypnotic Drugs

There are three major classifications for sedative-hypnotic drugs:

• Benzodiazepines: These drugs typically have suffixes of "-pam" or "-lam" (e.g., Diazepam, Alprazolam).
• Barbiturates: These drugs typically have suffixes or names like "-barbital," "-barbitol," or "-pental" (e.g., Phenobarbital).
• Miscellaneous agents (Z-drugs): These are relatively new agents for sedation and hypnosis. Most begin with the letter "z."
  • Examples given: Salimplon, Solvedem, and Esofenclone.

Definitions and Pharmacodynamics of CNS Receptors

• Sedatives:
  • Defined as drugs that reduce anxiety.
  • Otherwise termed as anxiolytics.
  • They exert a calming and relaxing effect.
• Hypnotics:
  • Defined as drugs that produce drowsiness and encourage the onset and maintenance of a state of sleep.
  • These involve more pronounced CNS depression than simple sedation.
• Note: Benzodiazepines and Barbiturates often perform both actions (sedation and hypnosis) and can be used for general anesthesia or control measures.
• GABA-A Receptor Mechanism:
  • The receptor acts as a "lock" for these drugs.
  • GABA is the inhibitory neurotransmitter that stimulates the $GABA_A$ receptor.
  • This receptor is the target for benzodiazepines, barbiturates, and related Z-drugs.
  • Activation increases the movement of the chloride ion channel ($Cl^-$).
  • Benzodiazepine Action: Increases the frequency of the chloride ion channel opening.
  • Barbiturate Action: Increases the duration of the chloride ion channel opening (mnemonic: "Barbi-duration").
  • Intracellular effect: The opening of these channels increases the negative intracellular charge.

Pharmacological Effects and Adverse Profiles

• Anxiolysis: The "lysis" or breaking of anxiety for the patient.
• Promotion of sedation and hypnosis.
• Anticonvulsant activity.
• Anterograde Amnesia: This effect is specifically highlighted as being associated with benzodiazepines that increase the frequency of chloride ion channel opening.
• Respiratory Depression: Since benzodiazepines are CNS depressants, they depress respiration and ventilation at high doses.
  • Caution: This is worse in patients with COPD (Chronic Obstructive Pulmonary Disease).
• Dependence and Abuse: Similar to opioids, benzodiazepines can create dependence, addiction, and abuse potential.
• Drug Interactions: Used with caution with valproic acid, as it may cause psychosis.
• Barbiturate-Specific Adverse Profile:
  • Distinct binding sites from benzodiazepines on the $GABA_A$ receptor.
  • High dependence liability.
  • Potential for fatal circulatory and respiratory depression.
  • Induced Contraindication: Barbiturates are contraindicated in patients with porphyria.
  • Enzyme Induction: They are potent inducers of the $CYP450$ enzyme system.

Clinical Applications of Benzodiazepines

• Chlordiazepoxide is specifically identified as the drug of choice for alcohol withdrawal.

Characteristics of Barbiturates and Z-Drugs

• Phenobarbital: Identified as the drug of choice for neonatal seizures.
• Z-Drugs (Salimplon, Solvedem, and Esofenclone):
  • Mode of action: Binds selectively to a specific subgroup of $GABA_A$ receptors.
  • Act similarly to hypnotics for the onset of sleep.

Comparison of Safety Profiles: Benzodiazepines vs. Barbiturates

• Barbiturates (Linear Slope):
  • Barbiturates show a linear dose-response curve.
  • As the dose increases, the effect progresses from sedation to hypnosis to anesthesia and then to medullary depression and death.
  • Proportionately greater doses do not have a ceiling; they lead to fatal CNS depression.
• Benzodiazepines (Ceiling Effect):
  • Benzodiazepines have a safer profile.
  • As the dosage increases, they reach a "ceiling effect."
  • This means they are less likely to lead to the fatal level of medullary depression compared to barbiturates.

Endocrine System and Clinical Conditions

• Anterior Pituitary Gland: Releases six major hormones, including $ACTH$.
• Autoimmune Diseases: It is noted that women are five times more likely to develop immune diseases.
• Graves' Disease:
  • Significantly more frequent in females.
  • Associated with infertile women.
  • Shows a strong familial association or family history.